C
ANIK icon

Covestor’s Anika Therapeutics ANIK Stock Holding History

Covestor’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Buy
+42
New +$488 ﹤0.01% 1966
2025
Q4 		– Sell
-35
Closed – – 2233
2025
Q3 		$0 Buy
35
+18
+106% +$172 ﹤0.01% 2246
2025
Q2 		$0 Buy
17
+13
+325% +$164 ﹤0.01% 2169
2025
Q1 		$0 Sell
4
-3
-43% -$50 ﹤0.01% 2177
2024
Q4 		$0 Buy
7
+3
+75% +$59 ﹤0.01% 2196
2024
Q3 		$0 Sell
4
-8
-67% -$207 ﹤0.01% 2174
2024
Q2 		$0 Sell
12
-12
-50% -$311 ﹤0.01% 2207
2024
Q1 		$1K Buy
24
+13
+118% +$315 ﹤0.01% 1891
2023
Q4 		$0 Buy
11
+2
+22% +$41 ﹤0.01% 2107
2023
Q3 		$0 Hold
9
– – ﹤0.01% 2077
2023
Q2 		$0 Sell
9
-15
-63% -$401 ﹤0.01% 2096
2023
Q1 		$1K Sell
24
-12
-33% -$357 ﹤0.01% 1817
2022
Q4 		$1K Sell
36
-82
-69% -$2.33K ﹤0.01% 1832
2022
Q3 		$3K Buy
+118
New +$2.72K ﹤0.01% 1597

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Covestor's ANIK Position: Q1 2026 in Review

Covestor opened a new position in Anika Therapeutics (ANIK) in Q1 2026: 42 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1966 among its holdings. This is a return to the name: Covestor previously reported a position in ANIK as recently as Q3 2025.

Covestor first reported a position in ANIK in Q3 2022 and has held it in 14 quarters since. The position peaked at $3K in Q3 2022. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Covestor held 42 shares of Anika Therapeutics worth $1K as of Q1 2026.
  • Anika Therapeutics was a new Covestor position in Q1 2026.
  • Anika Therapeutics made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #1966 holding.
  • Covestor first reported a position in Anika Therapeutics in Q3 2022 and has held it in 14 quarters since.
  • Covestor's Anika Therapeutics position peaked at $3K in Q3 2022.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.